| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |